18. DVFK-JAHRESTAGUNG IN BRAUNSCHWEIG Datum: 06.09.2014 Ort: Ärztehaus, An der Petrikirche 1, 38100 Braunschweig AKTUELLE KARDIOLOGIE & INTERESSANTE KASUISTIKEN Programm: 8.45 Eröffnung: S.H. Nguyen, Präsident DVFK / Helmstedt Begrüßung: H. Binkhoff, Vorsitzender der ÄK BS 8.55 Einleitung: R. Engberding, Präsident VGAC/Wolfsburg I. Sitzung: Kardiologie Update 2014 Vorsitz: R. Engberding (Wolfsburg) / V. Klauss (München) 09:00 Chirurgische Behandlung der Endokarditis W. Harringer (Braunschweig) 09:25 Ventrikuläre Arrhythmien J. Tebbenjohanns (Hildesheim) 09:50 Sport und Arrhythmien B. Gerecke (Peine) 10:15 Vorhofflimmern: Stellenwert der Antiarrhythmika- und Ablationstherapie D.Q. Nguyen (Köln) 10:40 Pause II. Sitzung: Echokardiographie & interessante Kasuistiken Vorsitz: G.D. Kneissl (Mainz), K-W. Diederich (Helmstedt) 11:00 Echokardiographie bei Kunstklappen, Bioprothesen und nach perkutaner Klappenintervention/TAVI W. Fehske (Köln) 11:25 Neurologisch-kardiologische Kasuistik M. Görtler (Magdeburg) 11:50 Stressechokardiographie I. Kruck (Ludwigsburg) 12:15 Rechtsventrikulärer Myokardinfarkt C. Fleischmann (Wolfsburg) 12:40 Schlusswort B. Gerecke im Anschluss gemeinsamer Imbiss und weitere Diskussion 14:00 DVFK-Mitgliederversammlung REFERENTEN UND GÄSTE:
Grußwort von Dr. Hubert Binkhoff, Vorsitzender der Ärztekammer Braunschweig Prof. Dr. Rolf Engberding (Wolfsburg) PD Dr. Wolfgang Harringer (Braunschweig) Prof. Dr. Klaus von Olshausen (Heidelberg) Prof. Dr. Jürgen Tebbenjohanns (Hildesheim) Dr. Birgit Gerecke (Peine) Dr. Dinh Quang Nguyen (Köln) PD Dr. Wolfgang Fehske (Köln) Dr. Claus Fleischmann (Wolfsburg) Dr. Stefan Kotthoff (Münster)
0 Comments
DVFK-Delegation: Prof. H.-F. Vöhringer, Prof. H.V. Tien (Uni Hue), Prof. S.H. Nguyen, Dr. K. Schlotterbeck, Prof. H.V. Minh (Uni Hue) Dr. B. Gerecke, Prof. V. Klauss, Prof. T. Budde, Dr. D.Q. Nguyen VIETNAMESE GERMAN SYMPOSIUM Hue University of Medicine and Pharmacy 29.11.2013 08:00 - 13:00 Organization:
Lectures: Latest Important Clinical Trials in Cardiology (2012-2013) - An Overview Prof. Dr. med. Thomas Budde, F.E.S.C., European Cardiologist, Director, Department of Internal Medicine and Cardiology, Alfried Krupp Hospital, Alfried-Krupp-Straße 21, D-45117 Essen Phone: +49-201-434-2524/2525, Fax: +49-201-434-2376 E-mail: thomas.budde@krupp-krankenhaus.de Introduction: Purpose of this presentation is to give an overview about the latest cardiologic trials published in years 2012-2013. Only trials with direct, major relevance for everyday clinical practice are selected. This selection is part of a periodic lecture program of the academy of the German Cardiologic Society (DGK). Selected Trials/Publications: KERALA ACS Registry (25.478 consecutive pts. with ACS in Kerala/India, 2007-2009, 125 hospitals; thrombolysis vs. PCI; analysis of hospital admission and treatment modalities, in-hospital mortality and MACE-rates) (Eur Heart J 2013; 34:121-129)) SCAAR= Swedisch Coronary Angiography and Angioplasty Registry (64.436 pts.; coronary angiography in ACS; 54.419 (84.4%) of patients with significant coronary stenosis; analysis of mortality with BMI (body mass index) as a continuous variable. Findings in context of the `obesity paradox`) (Eur Heart J 2013; 34:345-353); Metaanalysis of Stent Thrombosis after Coronary Intervention: Drug Eluting Stents (DES) (49 studies, >50.000 pts.; Everolimus: 16 studies / Paxitacel: 26 studies / Sirolimus: 20 studies; follow-up: 1-2 yrs., analysis for stent thrombosis after 30 days and 2 years) (Lancet 2012; 379:1393-1402); Pooled Data Analysis of the ISAR-TEST 3-, ISAR-TEST 4- and LEADERS-STUDY (Efficacy and clinical long-term results of biodegradable polymer stents vs. non biodegradable Sirolimus-eluting stents; pooling of the data of 3 large randomised multicenter trials; 4.062 pts; 2.358 biodegradable stents; follow-up: 4 years; analysis for late stent thrombosis and myocardial infarction) (Eur Heart J 2012; 33:1214-1222) ; Long-Term (>10 Years) Clinical Outcomes of First In-Human Biodegradable Poly-I-Lactic Acid Coronary Stents (50 pts.; 84 biodegradable Igaki-Tamai-Stents= bioresorbable Stents without drug elution; follow up >120 months; 87% survival; analysis for acute stent thrombosis and coronary re-interventions) (Circulation 2012; 125:2343-2352); RELY-ABLE (analysis of patients still being on study medication at the last check of the RELY-Study (pts. with atrial fibrillation; dabigatran vs. warfarin; 5.851 pts; median follow-up: 2.3 years; analysis for stroke, systemic embolism, major bleedings or deaths, resp., per year) (CirculationAHA 2013, published online before print); PROTECT-AF (707 pts.; non-valvular atrial fibrillation + at least 1 major risk factor for stroke; randomisation on closure of left atrial appendage (WatchmanR device) vs. Warfarin; endpoints: stroke, systemic embolism, death; non-inferiority trial) (Circulation 2013; 127:720-729); PARTNER Cohort A Trial (1.057 pts with severe aortic stenosis; 699 high-risk / 351 with contraindications for surgery; patients with high-risk randomised to surgery or TAVI (=transaortic valve implantation via catheter); follow-up > 3 years; analysis for endpoints of mortality, stroke, and other clinical factors) (1 year results: NEJM 2011 / 2 year results: NEJM 2012 / 3 year results: ACC meeting 2013, San Francisco; oral presentation); SYNTAX-Trial (1.800 pts.; 5 years-results; coronary bypass graft surgery vs. PCI in patients with three vessel- or left main coronary disease; endpoints: MACE, stroke, myocardial infarction, repeat revascularisation of target vessel, mortality) (Lancet 2013; 381:629-638); WOEST-Trial (573 pts; PCI in patients being on anticoagulant therapy; open-label, randomised, controlled trial; 284 pts. randomised to double therapy (anticoagulant + aspirin) vs. 289 pts randomised to triple therapy (anticoagulant + aspirin + clopidogrel); 1-year-results; analysis for stent thrombosis and a secondary combined endpoint of death, myocardial infarction, stroke or repaeat target vessel revascularisation) (Lancet 2013; 381:1107-1115). Summary: 10 recent cardiologic studies published 2012 to 2013 with great clinical impact were selected for this presentation. Topics/designs of the studies are listed above. The results of the studies will be explained and discussed during oral presentation. The presentation will be provided for the audience in digital format. Update on Differentiated Diagnosis and Risk Stratification of (Coronary) Heart Disease with a Special Focus on CT and MRI Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Introduction: Patient history, clinical risk factor assessment (including established scoring systems) and up-to-date non-invasive and/or invasive diagnostic strategies are fundamental for the diagnosis of coronary artery disease. These strategies include laboratory tests, electrocardiogram/echocardiogram at rest and under exercise, chest x-ray as well as cardio-CT or –MRI, nuclear cardiologic methods, invasive coronary angiography and intravascular ultrasound or Doppler. The use of the different methods is oriented to the clinical presentation of the patient and the pre-test probability of the presence or absence of significant CAD. Risk Stratification and Diagnosis: The pre-test probability of CAD can be estimated by the patient’s history (angina pectoris/dyspnoea/palpitations/nausea/faintness/syncope under rest and exercise?) and systematic risk factor analysis. Established risk factor scoring systems (e.g. FRAMINGHAM-/PROCAM-/EUROSCORE) can be helpful to characterize and quantify the individual risk of CAD in patients without a previous history of CAD or estimate the probability of coronary or other cardiac events in patients with known CAD. Whereas, in high risk situations or with clear clinical symptoms of CAD, the diagnostic algorithm will soon proceed to invasive coronary angiography, the low and very low risk situation will lead to non-invasive techniques and will more or less focus on analysis and modification of potentially existing risk factors. With intermediate pre-test probability of CAD, non-invasive techniques of coronary or myocardial imaging or tests to detect ischemia will be of high importance. Cardiac Computer Tomography (CT): Cardiac CT is able to detect coronary atherosclerosis by quantitative calcium scoring. High coronary calcium scores are related to the risk of chronic and acute coronary events, cardiac death and the development of significant coronary stenoses. Low or zero-calcium scores have a high negative predictive value (NPV) for excluding significant coronary artery disease. CT angiography may be a valuable tool for (1) exclusion of coronary artery disease prior to non-cardiac surgery in patients with intermediate cardiac risk, (2) patients with chronic angina pectoris with intermediate or low risk and inconsistent stress test results, (3) clarification of acute chest pain in patients with low or intermediate risk, normal ECG and normal laboratory results, (4) patients with newly developed heart failure without known CAD and low or intermediate coronary risk, (5) cases with suspected or known coronary anomaly, or (6) for sizing and planning before minimally invasive valve surgery. Cardiac MRI is able to visualize cardiac and coronary anatomy and to analyze ventricular wall motion and myocardial vitality (also in patients not suitable for echocardiography). With MRI stress testing techniques, functional aspects of ischemia and the need for interventional procedures can be guided. Late enhancement technique enables differentiating between (still) vital myocardial tissue and scar tissue. A negative stress-MRI is associated with a good long-term prognosis, whereas patient groups with inducible wall motion abnormalities in stress-MRI experience higher rates of myocardial infarction or cardiovascular death. The current clinical indications for cardiac MRI are: 1. Heart failure, 2. Coronary heart disease, 3. Valvular heart disease, 4. Diagnosis of cardiac masses, 5. Pericardial disease (constrictive pericarditis), 5. Congenital heart disease and 6. Pulmonary arterial disease or pulmonary embolism. Patients with new generations of cardiac pacemeakers may be no longer excluded from MRI imaging. Events and Prognosis in Noncompaction Cardiomyopathy - Data of the German Noncompaction Registry Dr. Birgit Gerecke, Prof. Dr. Rolf Engberding, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Isolated noncompaction cardiomyopathy (NCCM) is considered a primary genetic cardiomyopathy. Little is known about the prognosis of affected patients. The previous literature determines the prognosis by heart failure symptoms, varying arrhythmias and thrombembolic events, ranging from asymptomatic to maligne incidences. To further investigate this rare disease the German Noncompaction Registry (ALKK) was initiated in 2006. Patients were diagnosed by echocardiography having NCCM if at least four prominent trabeculations and deep intertrabecular recesses with blood flow from the LV cavity into the recesses were seen and if there was a typical bilaminar structure of the LV wall with an endocardial noncompacted layer (NC) and a compacted subepicardial layer (C) with NC>2xC. No other cardiac abnormalities should be present. By August 30th, 2013 the German NCCM registry had enrolled 320 patients (203 male, 117 female, age 18 to 88 years, mean age 52.9 years). The clinical data (functional status, medication, non pharmacological therapy) and clinical events (heart failure symptoms, any documented arrhythmias, embolic events) were reviewed, as were the ECG recordings and the echocardiography and MR images. As possible risk factors age, sex, severe heart failure symptoms (NYHA class III and IV), severely reduced LV ejection fraction (EF < 35%), LV dilatation (LVEDD > 5.5 cm), atrial fibrillation, LBBB and mitral regurgitation (> II°) were analysed. Heart failure symptoms (NYHA III/IV) were observed in 38% (122/320 pts). LBBB was seen in 21.8 %, atrial fibrillation in 19.1%, supraventricular tachycardia in 4%, bradycardia requiring a pacemaker system in 3.7 % and VT/VF in 14.7 % of the pts. 73 pts in the registry had an ICD implantation with primary (PP) or secondary (SP) preventive indication. 8 out of 38 pts with a PP indication in the group of pts with severely reduced LV function expired shock therapy, but none in the group with PP indication in the group with preserved LV function. There were 8.1 % deaths, 4% in pts with preserved LV function, 14.7 % in the group with EF < 35%. Age or sex could not be found as a risk factor for any event. No risk factor could be identified for thrombembolic events. LVEF < 35%, LV dilatation, atrial fibrillation. LBBB and mitral regurgitation were significant risk factors for a worse prognosis. Screening of the pts or relatives with NCCM should be performed for these parameters to induce proper therapy to enhance the prognosis. Seminar on Device Therapy: Indications for device therapy: update of ICD therapy , pacing and resynchronisation therapy 2013 Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Endoscopically guided Isolation of the pulmonary veins: a new approach in catheter based therapy of atrial fibrillation Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Electric isolation of the pulmonary veins (PVs) can successfully treat patients with paroxysmal atrial fibrillation. However, it remains technically challenging to identify the left atrial-PV junction and sequentially position the ablation catheter in a point-by-point contiguous fashion to isolate the PVs. A novel endoscopic ablation system was used to directly visualize and ablate tissue at the left atrial-PV junction with laser energy. After transseptal puncture, the balloon-based endoscopic ablation system was advanced to each PV ostium, and arcs of laser energy (90 degrees to 360 degrees ) were projected onto the target left atrial-PV junction. Electric PV isolation was defined with a circular multielectrode catheter. The durability of pulmonary vein isolation was investigated in a study, which is published in Heart Rhythm, June 2012. Acute success rate (complete PV isolation) was 98%. After a follow up period of 3 months, 86% of the PVs remained isolated. We present 6 month follow up success-rate data, in comparison to the PVAC-procedure, an alternate single shot device. Catheter Ablation of ventricular tachycardia: an overview Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Ablation of life-threatening ventricular tachycardia is still challenging. The indications for interventional therapy of VT`s will increasing in according to the increasing number of ICD and CRT-D-implantations and consecutive detected and treated ventricular tachyarrhythmias. As we know, that ICD-interventions, adequate as well as inadequate, are related with increased morbidity and mortality, an aggressive antiarrhythmic regimen is necessary. The OPTIC study has shown a disappointing effectiveness of Antiarrhythmic drugs (amiodarone, sotalole, betablockers). Studies on VT-ablation (V-TACH) has shown good success rate in the interventional group. Therefore a large amount of catheter ablation strategies are published: 3-D-electroanatomically guided substrate modification, epicardial approach, identification of late potentials are some of the keywords in the modern ablation strategy for ventricular tachycardia. An overview. CRT-D: newest guidelines, developments Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Anticoagulation in Atrial Fibrillation: Update 2013 Dr. Alexander Trompler, ACCR, Ravensburg, Germany Anticoagulation therapy in atrial fibrillation (AF) is enhanced by the novel oral thrombin- and factor Xa- inhibitors (NOACs). Dabigatran, rivaroxaban, apixaban, and edoxaban have now been approved or are currently in late-stage clinical development in AF. Based on the recent updates of the european society of cardiology guidelines for the management of AF, risk stratification strategies to reduce thromboembolic events in patients with AF will be reviewed. A special focus will be on the use of the NOACs in different clinical settings, e.g. renal insufficiency, elderly patients and patients with high risk of bleeding. Diagnosis and treatment of pulmonary embolism: Role of echocardiography Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany The pulmonary embolism is common and is a potentially life-threatening situation, especially if it is not recognized in time. In hemodynamically stable patients with suspected pulmonary embolism, CT pulmonary angiography is the gold standard for diagnostic imaging. In patients with acute hemodynamic deterioration with persistent arterial hypotension and/or cardiogenic shock of unknown cause must be thought generally to a differential diagnosis of pulmonary embolism. Echocardiography can shows indirect signs of pulmonary embolism (acute pulmonary hypertension and right ventricular overload or thromboembolic sources from the right heart) with possible different therapeutic consequences. Gender-specific aspects in the therapy of cardiovascular diseases Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany Cardiovascular diseases (CVD) are a major cause of mortality and morbidity for men and women. In 2011, about 42 % of all females’ death in Europe are caused by CVD, especially coronary heart disease and stroke (14%). It has been suggested that there is a gender difference in the clinical manifestation of CVD’s and in the response to therapy. The pharmacological response may differ in women when compared to men because of different endogenous hormone levels, a lower body weight, and a higher proportion of fat. Gender differences in enzyme activities involved in drug metabolism as well as a lower glomerular filtration rate which influences drug elimination have been demonstrated. Despite these relevant pharmacokinetic differences among cardiovascular drugs the impact on pharmacodynamics is often unknown a/o cannot be elucidated. The benefit of aspirin in primary prevention of myocardial infarction is less clear for women. Meta-analyses of ACE-inhibitor therapy in heart failure show for women a tendency towards less effective mortality and morbidity reduction. Adverse drug reactions in form of ACE-inhibitor cough occur twice as frequently in women. Reduction in blood pressure through calcium channel blockers is more pronounced in women than in man. For cardiac glycosides, there is evidence of a higher mortality in female patients with chronic heart failure. Torsades de pointes tachycardia occur in women under Antiarrhythmics as well as Non-antiarrythmics significantly more frequent than in men. The lack of more conclusive data on the magnitude of gender differences in response to cardio-vascular therapies should stimulate basic and clinical research to advance the knowledge on this topic. Does OCT replace IVUS in the cath lab – what do we need for intervention? Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center (ACCR), Ravensburg, Germany The gold standard for diagnostic imaging of the coronary arteries is still the angiography. Many limitations of this technique are known , so advancements have been developed. The use of intravascular ultrasound (IVUS) has enabled a transmural in vivo imaging of the coronary arteries while creating cross-sectional images of the vessel wall. The role of IVUS is to assess stent underexpansion and malapposition to identify coronary plaques with potential rupture, to plan intervention in complex cases, identify significant left main stem stenosis. The spectral analysis , derived from radiofrequency (RF) data enables more precise analysis of the plaque composition and plaque type. A new modality based on infrared light is the optical coherence tomography (OCT). With a resolution of 10-20 µm, which is better than IVUS this method provides intraluminal and extraluminal imaging of the vessels. Based on OCT it is able to distinguish between different tissue types, such as fibrous, lipid rich, necrotic or calcified tissue. OCT helps to assess patients with acute coronary syndrome with insights into plaque nature, rupture and progression. It also has been established as a gold standard for stent evaluation. Which stenosis should be treated? Lessions learned from coronary physiology Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany The decision for interventional treatment of a coronary lesion should be based on symptoms and prove of ischemia. However, in clinical practice, stenoses are often treated depending on the angiographic image, because symptoms are not clear and tests for ischemia have not been performed or the tests are inconclusive. By means of intracoronary pressure measurements (i.e. determination of fractional flow reserve - FFR) the hemodynamic relevance of a coronary stenosis can be determined during coronary angiography especially in intermediate lesions and thus the decision to treat or not to treat is based on an objective test of ischemia. Newer developments (instantaneous wave-free ratio – iFR) may facilitate the application of physiologic measurements in interventional cardiology. Surgery in acute endocarditis PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Treatment modalities for severe aortic stenosis - New technologies PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Faculty: PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Georg Dieter Kneissl Johannes Gutenberg-University Mainz, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Klaus Schlotterbeck, Cardiovascular Center (ACCR), Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center (ACCR), Ravensburg, Germany Prof. Dr. Dr. Reinhard Urban, Johannes Gutenberg-University Mainz, Germany Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany von li. nach re. 1.Reihe: Prof. V. Klauss (München), Prof. H.-F. Vöhringer (Berlin), Dr. B. Gerecke (Peine) 2. Reihe: Dr. K. Schlotterbeck (Ravensburg), Dr. D.Q. Nguyen (Köln), Prof. T. Budde (Essen) Zur Bearbeitung hier klicken Prof. H.V. Minh (Uni Hue), Prof. D.D. Loi (Ha Noi), Prof. C.N. Thanh (Rektor der Uni Hue), Dr. N.T.T. Hoai (Ha Noi), Prof. S.H. Nguyen (DVFK), Prof. N.H.Thuy (Uni Hue)
3. VIETNAMESE GERMAN Scientific Symposium
Nha Trang 27.11.2013 KHANH HOA HOSPITAL 13:00 - 17:00 Organization:
Lectures: Latest Important Clinical Trials in Cardiology (2012-2013) - An Overview Prof. Dr. med. Thomas Budde, F.E.S.C., European Cardiologist, Director, Department of Internal Medicine and Cardiology, Alfried Krupp Hospital, Essen, Germany Update on Differentiated Diagnosis and Risk Stratification of (Coronary) Heart Disease with a Special Focus on CT and MRI Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Events and Prognosis in Noncompaction Cardiomyopathy - Data of the German Noncompaction Registry Dr. Birgit Gerecke, Prof. Dr. Rolf Engberding, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Seminar on Device Therapy: Indications for device therapy: update of ICD therapy , pacing and resynchronisation therapy 2013 Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Endoscopically guided Isolation of the pulmonary veins: a new approach in catheter based therapy of atrial fibrillation Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Catheter Ablation of ventricular tachycardia: an overview Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany CRT-D: newest guidelines, developments Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Anticoagulation in Atrial Fibrillation: Update 2013 Dr. Alexander Trompler, ACCR, Ravensburg, Germany Diagnosis and treatment of pulmonary embolism: Role of echocardiography Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany Gender-specific aspects in the therapy of cardiovascular diseases Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany Does OCT replace IVUS in the cath lab – what do we need for intervention? Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center (ACCR), Ravensburg, Germany Which stenosis should be treated? Lessions learned from coronary physiology Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Surgery in acute endocarditis PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Treatment modalities for severe aortic stenosis - New technologies PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Faculty: PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Georg Dieter Kneissl Johannes Gutenberg-University Mainz, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Klaus Schlotterbeck, Cardiovascular Center (ACCR), Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center (ACCR), Ravensburg, Germany Prof. Dr. Dr. Reinhard Urban, Johannes Gutenberg-University Mainz, Germany Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany 13. VIETNAMESE GERMAN HEART DAYS
Ho Chi Minh City 25.11.2013 Organization:
Lectures: Latest Important Clinical Trials in Cardiology (2012-2013) - An Overview Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Update on Differentiated Diagnosis and Risk Stratification of (Coronary) Heart Disease with a Special Focus on CT and MRI Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Noncompaction-Cardiomyopathy- Results of the German-NCCM-Registry Dr. Birgit Gerecke, Prof. Dr. Rolf Engberding, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Indications for device therapy: update of ICD therapy , pacing and resynchronisation therapy 2013 Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Endoscopically guided ablation of the pulmonary veins: a new approach in catheter based therapy of atrial fibrillation Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Ablation of ventricular tachycardia: An overview Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Pacemaker, ICD und CRT-D: newest guidelines, developments Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Anticoagulation in Atrial Fibrillation: Update 2013 Dr. Alexander Trompler, ACCR, Ravensburg, Germany Diagnosis and treatment of pulmonary embolism: Role of echocardiography Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany Gender-specific aspects in the therapy of cardiovascular diseases Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany Does OCT replace IVUS in the cath lab – what do we need for intervention? Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center (ACCR), Ravensburg, Germany Which stenosis should be treated? Lessions learned from coronary physiology Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Surgery in acute endocarditis PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Treatment modalities for severe aortic stenosis - New technologies PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Faculty: PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Georg Dieter Kneissl Johannes Gutenberg-University Mainz, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Klaus Schlotterbeck, Cardiovascular Center (ACCR), Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center (ACCR), Ravensburg, Germany Prof. Dr. Dr. Reinhard Urban, Johannes Gutenberg-University Mainz, Germany Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany 17. DVFK-JAHRESTAGUNG IN BRAUNSCHWEIG Datum: 07.09.2013 Ort: Ärztehaus, An der Petrikirche 1, 38100 Braunschweig AKTUELLE KARDIOLOGIE & INTERESSANTE KASUISTIKEN Programm: 8.45 Eröffnung: S.H. Nguyen, Präsident DVFK / Helmstedt Begrüßung: H. Binkhoff, Vorsitzender der ÄK BS R. Urban, Universitätsmedizin Mainz 8.55 Einleitung: R. Engberding, Präsident VGAC/Wolfsburg I. Sitzung: interdisziplinäre klinische Kardiologie Vorsitz: V. Klauss (München), W. Fehske (Köln) 09:00 Übersicht über relevante kardiologische Studien 2012/13 T. Budde (Essen) 09:20 FITT-STEMI: Verbesserungen in der Infarktversorgung C. Fleischmann (Wolfsburg) 09:40 Interessante Kasuistik aus der Neurologie Uni Magdeburg M. Görtler (Magdeburg) 10:00 Behandlung der Aortenerkrankungen W. Harringer (Braunschweig) 10:20 Pause II. Sitzung: Bewährtes und Innovatives Vorsitz: G. Breithardt (Münster), R. Engberding (Wolfsburg) 10:40 Tako-Tsubo-Kardiomyopathie in der Medizin und in der Literatur B. Schneider (Lübeck) 11:00 Bedeutung der transösophagealen 3-D-Echokardiographie W. Fehske (Köln) 11:20 MitraClips Update 2013 S. v. Bardeleben (Mainz) 11:40 TAVI: apikaler Zugang: aktuelle Daten M. Anssar (Braunschweig) 12:00 Spezielle kardiologische Kasuistik B. Gerecke (Wolfsburg) 12:20 Pause III. Sitzung: Kardiologie im täglichen Alltag Vorsitz: T. Stein (Helmstedt), B. Gerecke (Wolfsburg) 12:40 Kryo-Ablation bei Vorhofflimmern J. Tebbenjohanns (Hildesheim) 13:00 Falldarstellungen: Ablation komplexer supraventrikulärer und ventrikulärer Tachykardien D.Q. Nguyen (Köln) 13:20 Genderaspekte bei der Therapie kardialer Erkrankungen H.-F. Vöhringer (Berlin) 13:40 Schlusswort B. Gerecke (Wolfsburg) im Anschluss gemeinsamer Imbiss und weitere Diskussion 14:30 DVFK-Mitgliederversammlung B.Gerecke, V. Klauss, G.D. Kneissl, S.H. Nguyen REFERENTEN UND GÄSTE:
Dr. B. Gerecke, Prof. Dr. R. Engberding, Prof. G. Breithardt Dr. C. Fleischmann, Prof. Dr. R. Engberding
UPDATE ON CARDIOLOGY 2012 & TRENDS OF DEVELOPMENT / HUE UNIVERSITY of MEDICINE and PHARMACY11/30/2012 VIETNAMESE GERMAN SCIENTIFIC SYMPOSIUM November 27th 2012 Khanh Hoa Hospital/Nha Trang/Vietnam Organization: Vietnamese Society of Cardiology Khanh Hoa Khanh Hoa Hospital Nha Trang Deutsch-Vietnamesischer Förderkreis für Kardiologie (DVFK) / German Vietnamese Association of Cardiology Vietnamese German Academy for Science and Education in Cardiology and Cardiovascular Surgery (VGAC) University Medical Center of the Johannes Gutenberg University Mainz EurAsia Heart Foundation 09:00 – 11:30 Greeting the delegation DVFK of the Directors of Khanh Hoa Hospital Visit to the Khanh Hoa Hospital: Echocardiography in the polyclinic Intensive care unit Cardiac catheterization Future Department of Cardiac Surgegy SCIENTIFIC PROGRAM 13:30 – 18:00 GREETING: 13:30-14:00 Dr. Nguyen Van Xang, Vice Director of Khanh Hoa Hospital Dr. Bui Xuan Minh, Director of the Department of Health Khanh hoa Prof. Dr. Dr. Reinhard Urban Dean of Faculty of Medicine of the Johannes Gutenberg-University Mainz, Germany Prof. Dr. Nguyen Si Huyen President of German Vietnamese Association of Cardiology (DVFK) Prof. Dr. Rolf Engberding Vietnamese German Academy for Science and Education in Cardiology and Cardiovascular Surgery (VGAC) 14:00 Noncompaction-Cardiomyopathy- Results of the German-NCCM-Registry Bệnh cơ tim biệt hóa kém: kết quả từ nghiên cứu sổ bộ của Đức Prof. Dr. Rolf Engberding, Academic Hospital Wolfsburg, Germany 14:20 Total arterial coronary artery bypass surgery: Indications and Principles Phẫu thuật bắc cầu động mạch vành: nguyên lý và chỉ định lâm sàng PD Dr. Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland 14:40 Cardio-CT Cat lop dien toan trong chan doan cac benh tim mach Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany 15:00 Best Integrated Prevention of Cardiovascular Disease in 2012 Dự Phòng Toàn Diện Tối Ưu BệnhTim Mạch 2012 Associate Prof. Tran Van Huy MD PhD FACC FESC 15.20 TEA BREAK 16:00 3D transthoracic and transesophageal echocardiographic examination: Standardisation, guidelines and new technical developments Siêu âm tim 3D qua thành ngực & qua thực quản: tiêu chuẩn, khuyến cáo thực hành lâm sàng & kỹ thuật PD Dr. Wolfgang Fehske, St. Vinzenz-Hospital, Köln, Germany 16:20 Role of drug eluting balloons for in-stent restenosis and small vessel diseases Giá trị của bóng phủ thuớc ở bệnh nhân tái hẹp trong stent và tổn thương mạch máu nhỏ Dr Huỳnh Văn Thưởng, Khanh Hoa Hospital 16:40 Endoscopic guided Isolation of the pulmonary veins: A new approach in catheter based therapy of atrial fibrillation Cô lập tĩnh mạch phổi dưới hướng dẫn nội soi: cách tiếp cận mới trong điều trị rung nhĩ bằng catheter Dr. Nguyen Dinh Quang, St. Vinzenz-Hospital, Köln, Germany 17:00 Dual vs. triple anticoagulant treatment in acute coronary syndrome and atrial fibrillation Điều trị phối hợp 2 hoặc 3 thuốc chống đông trong hội chứng mạch vành cấp và rung nhĩ Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin 17:20 Closing Remarks A. Prof. Dr. Tran Van Huy Faculty: PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Prof. Dr. Rolf Engberding, Medical Clinic I, Academic Hospital Wolfsburg, Germany PD Dr. Wolfgang Fehske, St. Vinzenz-Hospital, Köln, Germany Associate Prof. Tran van Huy, President of Heart Association Khanh Hoa Prof. Dr. Georg Dieter Kneissl, Johannes Gutenberg-University Mainz, Germany Dr. Bui Xuan Minh, Director of the Department of Health Khanh hoa Dr. Si Huyen Nguyen,Ass. Prof. of Cardiology and intensive Care Medicine, Medical University Pham Ngoc Thach/HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Nguyen Dinh Quang, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Dr. Reinhard Urban, Dean of Faculty of Medicine of the Johannes Gutenberg-University Mainz, Germany Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin Dr Nguyên Manh Tien, Director of Khanh hoa Hospital Dr. Nguyen Van Xang, Vice Director of Khanh hoa Hospital Dr Tran Quynh Hoa, Vice Director of Khanh hoa Hospital Dr Cao Viet Dung, Vice Director of Khanh hoa Hospital Dr. Huynh Van Thuong, Intensive Care Unit and Interventional Cardiac Unit KH Hospital Dr Le Thuong, Department of Cardiovascular Surgery Khanh Hoa Hospital Dr Luong Linh Ha, Department of Image Diasnostis. Cardiology Khanh Hoa Hospital Dr Tran Vo Vinh Son, Department of Cardiology Khanh Hoa Hospital Dr Mai Quang Ngoc, Department of Cardiology Khanh Hoa Hospital Dr Tran Thi Nhu Nam, Department of Cardiology Khanh Hoa Hospital Dr Pham Dinh Chi, Intensive Care Unit, Khanh Hoa Hospital Dr. Nguyen Van Xang, Direktor des Khanh Hoa General Hospitals begrüßt die DVFK-Delegation. Besuch der neuen MRT-Anlage des Hospitals Besichtigung neuer Anlage für die Intensivstation und herzchirurgische Abteilung. Gruppenphoto mit Dr. Nguyen Van Xang, Direktor der Klinik (in der Mitte) und den Klinikärzten. 16. DVFK-JAHRESTAGUNG IN BRAUNSCHWEIG
Datum: 01.09.2012 Ort: Ärztehaus, An der Petrikirche 1, 38100 Braunschweig AKTUELLE KARDIOLOGIE: Bewährtes und Innovatives Programm: 8.45 Eröffnung: S.H. Nguyen, Präsident DVFK / Helmstedt Begrüßung: H. Binkhoff, Vorsitzender der ÄK BS D.V. Phuoc, Präsident der Vietnamesischen Kardiologischen Gesellschaft Ho Chi Minh City R. Urban, Wissenschaftlicher Vorstand, Universitätsmedizin Mainz 8.55 Einleitung: R. Engberding, Präsident VGAC/Wolfsburg I. Sitzung: Interdisziplinäre klinische Kardiologie Vorsitz: R. Engberding (Wolfsburg), S.H.Nguyen (Helmstedt) 09:00 Kardiale Synkope: Diagnostik und Therapie B. Gerecke (Wolfsburg) 09:25 Neurologische Abklärung in der Synkopendiagnostik M. Görtler (Magdeburg) 09:50 Marfan-Syndrom: was muss der Kardiologe wissen? S. Kotthoff (Münster) 10:15 Chirurgische Behandlung der Endokarditis M. Anssar (Braunschweig) 10:40 Pause II. Sitzung: Update 2012: Bewährtes und Innovatives Vorsitz: V. Klauss (München), T. Bartel (Innsbruck) 11:00 Endovaskuläre renale Sympathektomie als therapeutische Möglichkeit medikamentenresistenter arterieller Hypertonie J. Monti (Berlin) 11:25 Bedeutung der 3-D-Echokardiographie bei Herzkatheterinterventionen S. v. Bardeleben (Mainz) 11:50 MitraClip-Implantation: Patientenselektion, Sicherheit und Effektivität T. Bartel (Innsbruck) 12:15 Chirurgische Mitralklapppenrekontruktion P. Berdat (Zürich) 12:40 Pause III. Sitzung: Kardiologie im täglichen Alltag Vorsitz: T. Budde (Essen), GD Kneissl (Mainz) 13:00 Therapie der chronischen Herzinsuffizienz: Update 2012 A. Schmeißer (Magdeburg) 13:25 Differentialdiagnose der tachykarden Herzrhythmusstörungen mit schmalem QRS-Komplex K.v.Olshausen (Heidelberg 13:50 Antithrombotische Dreifachtherapie bei kardiovaskulären Risikopatienten H.-F. Vöhringer (Berlin) 14:15 Interventionskardiologie bei alten Patienten T. Budde (Essen) 14:40 Schlusswort G.D. Kneissl im Anschluss gemeinsamer Imbiss und weitere Diskussion 15:00 DVFK-Mitgliederversammlung REFERENTEN UND GÄSTE:
Gesundheitswesen in Vietnam: Fortschritt durch Austausch
http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=118001 2011 11. Vietnamese German Heart Days in HCMC 25.11.2011-27.11.2011 Ho-Chi-Minh City Conference venue: Conference rooms of the People's Committee of Ho Chi Minh City Organization:
In Cooperation with
Introduction Prof. Dang Van Phuoc President of Vietnamese Society of Cardiology at HCM City Ass. Prof. Dr. Nguyen Si Huyen President of German Vietnamese Association of Cardiology Welcome addresses Prof. Nguyen Tan Binh Rector of Medical University Pham Ngoc Thach Prof. Dr. Dr. Reinhard Urban Dean of Faculty of Medicine of Johannes Gutenberg University Mainz Scientific Symposium Lectures Echocardiographic Evaluation of Diastolic Left Ventricular Function Dr. Alexander Trompler, ACCR, Ravensburg, Germany Strategies in the treatment of coronary bifurcation stenosis Dr. Christoph Rieckmann, Ludwigsburg, Germany Assessment of Valvular Heart Disease using 3D-Echocardiography PD Dr. Ralph Stephan v. Bardeleben, Department of Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Germany Assessment of Myocardial Function using 3-Echocardiography PD Dr. Ralph Stephan v. Bardeleben, Department of Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Germany Role of echocardiography in the diagnosis and treatment of pulmonary embolism Dr. Si Huyen Nguyen, Department of Cardiology, Intensive Care and Sleep Medicine, HELIOS St. Marienberg Clinic Helmstedt, Academic Hospital of the University Magdeburg, Germany Obstructive sleep apnea and cardiac arrhythmias Dr. Si Huyen Nguyen, Department of Cardiology, Intensive Care and Sleep Medicine, HELIOS St. Marienberg Clinic Helmstedt, Academic Hospital of the University Magdeburg, Germany Pacemaker and ICD therapy in 2011 and future prospects Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Update on Differentiated Diagnosis and Risk Stratification of Coronary Artery Disease with a Special Focus on Modern Imaging Techniques (Cardio-CT/-MRI) Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany New technologies in echocardiography: tissue doppler and speckle tracking/2-D-Strain; implementation in daily workflow Dr. Irmtraut Kruck, Ludwigsburg, Germany Mitral valve repair in rheumatic disease PD Dr. Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Aortic root surgery today PD Dr. Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland Efficacy and safety of new factor Xa and thrombin inhibitors compared to vitamin K antagonists in patients with non-valvular atrial fibrillation. Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin New angiographic diagnostic techniques in the cath lab – what do we need? Dr. Klaus Schlotterbeck, Cardiovascular Center (ACCR), Ravensburg, Germany Seminares: German- Vietnamese Meeting on Interventional Cardiology Interactive Demonstration and Discussion of Coronary Interventions: technical aspects, complications… PD Dr W. Zwehl, Dr. K. Schlotterbeck, Prof. Dr. V. Klauss, Dr. C. Rieckmann and Vietnamese Cardiologists „Pacemaker and ICD therapy“ Dr. Birgit Gerecke, Medical Clinic I, Department of Cardiology, Academic Hospital Wolfsburg, Germany Faculty: PD Dr. med Pascal André Berdat, Department of Cardiovascular Surgery, Clinic in Park, Zurich, Switzerland PD Dr. Ralph Stephan v. Bardeleben, Department of Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Germany Prof. Dr. Thomas Budde, Medical Clinic I, Department of Cardiology, Alfried Krupp Hospital, Essen, Germany Dr. Birgit Gerecke, Medical Clinic I, Academic Hospital Wolfsburg, Germany Prof. Dr. Volker Klauss, Cardiology Innenstadt, Munich, Germany Prof. Dr. Georg Dieter Kneissl Johannes Gutenberg-University Mainz, Germany Dr. Irmtraut Kruck, Ludwigsburg, Germany Dr. Si Huyen Nguyen, ass. Professor of Cardiology and intensive Care Medicine, Medical University Pham Ngoc Thach/HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Christoph Rieckmann, Ludwigsburg, Germany Dr. Klaus Schlotterbeck, Cardiovascular Center (ACCR), Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center (ACCR), Ravensburg, Germany Prof. Dr. Dr. Reinhard Urban, Dean of Faculty Medicine, University Medical Center of Johannes Gutenberg University Mainz, Germany Prof. Dr. Hans-F. Voehringer, DRK Kliniken Berlin, Germany PD Dr. Werner Zwehl, Munich, Germany Anlage: SCIENTIFIC PROGRAMM der Vietnamesischen Kardiologischen Gesellschaft in Ho-Chi-Minh City Hội thảo chuyên đề siêu âm tim Echocardiography Symposium 2011 Friday, 25th November 2011 “New perspectives in Echocardiography” ORGANISING COMMITTEE CHAIRPERSON Prof. Pham Nguyen Vinh SCIENTIFIC COMMITTEE Prof. Pham Gia Khai Prof. Do Doan Loi Prof. Truong Quang Binh SECRETARY Dr. Dinh Duc Huy CHƯƠNG TRÌNH HỘI THẢO SCIENTIFIC PROGRAM 09.00- 09.10 Phát biểu khai mạc hội thảo GS.TS. Phạm Gia Khải Opening speech Session 1 Chairpersons : GS. TS. Phạm Gia Khải PGS. TS. Phạm Nguyễn Vinh 09.10- 09.30 Khuyến cáo của Hội tim mạch Việt nam PGS.TS. Phạm Nguyễn Vinh về bệnh tim bẩm sinh Vietnam Heart Association guidelines for congenitale heart disease 09.30- 09.50 Khảo sát tần suất dị tật tim thai trên một ThS. BS. Lê Kim Tuyến quần thể sản phụ tại TP HCM Prevalence of cardiac defects detected by fetal echocardiography in pregnancy women in HCMC 09.50- 10.10 Thiểu sản thất trái : bệnh lý tim thai BS. Huỳnh Thanh Kiều cần được phát hiện sớm Hypoplastic left heart syndrome : an abnormality can be early detected on fetal echocardiography 10.10- 10.30 Siêu âm tim 3 chiều đánh giá bệnh lý van tim Dr. Ralph v. Bardeleben và chức năng thất trái New perspectives of cardiac evaluation : 3D echocardiography in valvular and ventricular function 10.30-10.50 Vai trò của siêu âm tim trong chẩn đoán Prof. Nguyen Si Huyen và điều trị bệnh lý thuyên tắc phổi Role of echocardiography in diagnosis and treatment of pulmonary embolism 10.50- 11.10 Vai trò của siêu âm tim trong đánh giá TS. BS. Lê Thanh Liêm mất đồng bộ tim Echocardiographic evaluation of cardiac dyssynchrony 11.10- 11.30 Độ nhậy siêu âm tim thai tại Viện tim TPHCM ThS. BS. Lê Kim Tuyến Sensitivity of fetal echocardiography in Heart Institute of HoChiMinh city 11.30- 11.50 Nghiên cứu biến đổi hình thái và chức năng BS. Trần Văn Trung động mạch cảnh ngoài sọ bằng siêu âm Doppler ở bệnh nhân nhồi máu não Evaluation of extracranial carotid artreries by Carotid Duplex Ultrasonogarphy in stroke patients ----------------------------------------------------------------------------------------------------------------------------------------------------- 12.00- 13.00 Hội thảo vệ tinh- GE GE Luncheon symposium ----------------------------------------------------------------------------------------------------------------------------------------------------- 13.10- 13.30 Siêu âm tim Dobutamin đánh giá chức năng BS. Đoàn Hữu Linh tâm trương trong chẩn đoán bệnh cơ tim TMCB Diastolic dysfunction evaluation by Dobutamine echocardiography in the diagnosis of ischemic heart disease 13.30- 13.50 Siêu âm tim Dobutamin liều thấp tiên đoán ThS. BS. Nguyễn T Mỹ Hạnh hồi phục chức năng thất trái sau can thiệp ĐMV qua da trên bệnh nhân sau NMCT cấp Left ventricular recovery prediction by low dose Dobutamine echocardiography in STEMI patients 13.50- 14.10 Nghiên cứu vận động vòng van 3 lá trong đánh giá BS. Nguyễn Liên Nhựt chức năng tâm thu thất phải ở bệnh nhân bệnh cơ tim giãn Evaluation of RV systolic function by TAPSE in patients with dilated cardiomyopathy 14.10- 14.30 Khảo sát mối tương quan giữa bề dày lớp nội BS. Dương Phi Sơn trung mạc động mạch cảnh và bệnh ĐMV Relationship between carotid intima-media thickness and coronary artery disease 14.30- 14.50 Cập nhật các hướng dẫn thực hành siêu âm ThS. BS. Lê Kim Tuyến tim thai Updates of clinical guidelines for fetal echocardiography 14.50- 15.00 Phát biểu bế mạc hội thảo PGS.TS. Phạm Nguyễn Vinh Closing remarks DVFK-Delegation an der 10. regionalen wissenschaftlichen Tagung der vietnamesischen kardiologischen Gesellschaft im Süden vom 25.11.2011 - 27.11.2011 in Ho Chi Minh City Prof. D.V. Phuoc, Präsident HCMC Cardiovascular Association bei der Begrüßung der DVFK-Teilnehmer Prof. G.D. Kneissl bei Begrüßung der Kongressteilnehmer |
Archiv
November 2019
|